VEXAS syndrome: Clinical manifestations, diagnosis, and treatment
Authors:
- Michelle Patricia Loeza-UribeMLMichelle Patricia Loeza-Uribe
- Andrea Hinojosa-AzaolaAHAndrea Hinojosa-Azaola
- Beatriz E. Sánchez-HernándezBSBeatriz E. Sánchez-Hernández
- José C. CrispínJCJosé C. Crispín
- Elia Apodaca-ChávezEAElia Apodaca-Chávez
- Marcela A. FerradaMFMarcela A. Ferrada
- Eduardo Martín-NaresEMEduardo Martín-Nares
- 29 December 2023
- journal article
- review article
- Published by Elsevier in Reumatología Clínica (English Edition)
- Vol. 20 (1) , 47-56
Abstract
No abstract availableThis publication has 70 references indexed in Scilit:
- VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapyRheumatology, 2021
- Vacuolization of hematopoietic precursors: an enigma with multiple etiologiesBlood, 2021
- Therapeutic options in VEXAS syndrome: insights from a retrospective seriesBlood, 2021
- Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory DiseaseNew England Journal of Medicine, 2020
- Crystal structure of a human ubiquitin E1–ubiquitin complex reveals conserved functional elements essential for activityJournal of Biological Chemistry, 2018
- Regulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and AutoimmunityFrontiers in Immunology, 2018
- UBA1: At the Crossroads of Ubiquitin Homeostasis and NeurodegenerationTrends in Molecular Medicine, 2015
- Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyondSeminars in Immunopathology, 2015
- The Ubiquitination Machinery of the Ubiquitin SystemThe Arabidopsis Book, 2014
- Ubiquitin-activating enzyme UBA1 is required for cellular response to DNA damageCell Cycle, 2012